Core Viewpoint - 瑞康医药's stock experienced a significant increase, reaching the daily limit with a turnover rate of 24.58% and a transaction volume of 1.282 billion yuan, indicating strong market interest and volatility [2]. Trading Activity - The stock's price rose by 10.10%, leading to its inclusion on the Shenzhen Stock Exchange's watchlist for significant price deviation [2]. - Institutional investors net sold 22.4579 million yuan, while total net selling from brokerage seats amounted to 6.3127 million yuan [2]. - The top five brokerage seats accounted for a total transaction volume of 208 million yuan, with buying amounting to 89.6331 million yuan and selling at 118 million yuan, resulting in a net sell of 28.7706 million yuan [2]. Fund Flow - The stock saw a net outflow of 88.0528 million yuan from major funds, with large orders contributing to a net outflow of 53.1893 million yuan and big orders at 34.8636 million yuan [2]. - Over the past five days, the stock experienced a net inflow of 53.4196 million yuan [2]. Margin Trading - As of December 3, the margin trading balance for 瑞康医药 was 203 million yuan, with a financing balance of 202 million yuan and a securities lending balance of 484.7 thousand yuan [2]. - In the last five days, the financing balance decreased by 20.2736 million yuan, representing a decline of 9.12%, while the securities lending balance increased by 55.3 thousand yuan, showing a rise of 12.89% [2].
瑞康医药涨停,龙虎榜上机构买入1252.61万元,卖出3498.40万元